Log In
Print
BCIQ
Print
Print this Print this
 

Mabtas, Biosimilar rituximab

  Manage Alerts
Collapse Summary General Information
Company Intas Pharmaceuticals Ltd.
DescriptionBiosimilar of rituximab
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today